Annual General Meeting 2026

BioNTech's Annual General Meeting was held on May 15, 2026, without the physical presence of shareholders or their proxies (with the exception of the company's proxies), with 92.00 percent of the registered share capital represented. The shareholders approved all resolutions. The voting results can be found on this page.

 

Letter from Helmut Jeggle, Chairman of the Supervisory Board of BioNTech

Information and Documents Relating to the Annual General Meeting

Invitation to the 2026 Annual General Meeting

Documents on Agenda Item 1

Documents on Agenda Item 2

Documents on Agenda Item 6

Documents on Agenda Item 8

Documents on Agenda Item 10

Documents on Agenda Item 11

Draft domination and profit and loss transfer agreement between BioNTech SE and BioNTech Discovery GmbH 269.9 KB
Joint Report of the Management Board of BioNTech SE and the Management of BioNTech Discovery GmbH on the domination and profit and loss transfer agreement pursuant to Section 293a of the German Stock Corporation Act 322.7 KB
Financial Statements of BioNTech Discovery GmbH for the short financial year from 27 May 2025 to 31 December 2025 115.1 KB
BioNTech SE Annual Financial Statements as of 31 December 2023 749.1 KB
BioNTech Annual Report 2023 with the Consolidated Financial Statements as of 31 December 2023, the Combined Management Report for BioNTech SE and the Group and the Report of the Supervisory Board for the 2023 financial year 13.3 MB
BioNTech SE Annual Financial Statements as of 31 December 2024 1.6 MB
BioNTech Annual Report 2024 with the Consolidated Financial Statements as of 31 December 2024, the Combined Management Report for BioNTech SE and the Group and the Report of the Supervisory Board for the 2024 financial year 15.9 MB
BioNTech SE Annual Financial Statements as of 31 December 2025 6 MB
BioNTech Annual Report 2025 with the Consolidated Financial Statements as of 31 December 2025, the Combined Management Report for BioNTech SE and the Group and the Report of the Supervisory Board for the 2025 financial year 19.5 MB

Further Documents and Forms

Speech and Presentation

Voting Results

BioNTech SE

An der Goldgrube 12

55131 Mainz, Germany

T: +49 6131 9084-0

F: +49 6131 9084-2121

service@biontech.de

© 2026  BioNTech
All rights reserved